{"entity":{"id":"da-roadmap-anti-amyloid","kind":"roadmap","name":"Anti-amyloid medicines","aka":[],"tldr":"From failed or withdrawn antibodies to two US-approved early-stage products, with access and ARIA still open.","summary":"This roadmap is a teaching timeline for the Alzheimer’s antibody story on this atlas. It is not a prediction that more antibodies will help more stages.","asOf":"2026-09-21","links":[{"label":"FDA Leqembi","url":"https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval"}],"tags":["dementia-atlas"],"related":[],"cancers":["alzheimers-disease"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"steps":[{"era":"2016-2019","title":"Large antibody failures","description":"EXPEDITION 3 and ENGAGE show that amyloid lowering is not automatically clinical benefit.","refs":["da-trial-expedition3","da-trial-engage"],"status":"historic"},{"era":"2021-2024","title":"Approvals and a withdrawal","description":"Aducanumab is authorised then withdrawn. Lecanemab and donanemab reach US labels for early disease.","refs":["da-aducanumab","da-lecanemab","da-donanemab"],"status":"current"},{"era":"2025-","title":"Access, mixed disease, next targets","description":"Who is treated, who is monitored, and whether tau or blood-first triage changes the funnel.","refs":["da-remternetug","da-idea-blood-first-triage"],"status":"emerging"}]},"route":"/roadmaps/da-roadmap-anti-amyloid/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}],"trial":[{"id":"da-trial-engage","kind":"trial","name":"ENGAGE","route":"/trials/da-trial-engage/"},{"id":"da-trial-expedition3","kind":"trial","name":"EXPEDITION 3","route":"/trials/da-trial-expedition3/"}],"drug":[{"id":"da-aducanumab","kind":"drug","name":"Aducanumab","route":"/drugs/da-aducanumab/"},{"id":"da-donanemab","kind":"drug","name":"Donanemab","route":"/drugs/da-donanemab/"},{"id":"da-lecanemab","kind":"drug","name":"Lecanemab","route":"/drugs/da-lecanemab/"},{"id":"da-remternetug","kind":"drug","name":"Remternetug","route":"/drugs/da-remternetug/"}],"idea":[{"id":"da-idea-blood-first-triage","kind":"idea","name":"Blood test before PET or lumbar puncture","route":"/ideas/da-idea-blood-first-triage/"}]}}